Zilver PTX Post-Market Study in Japan
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 909 participants.
Also called NCT02254837
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 909 participants
- Sponsor
- Registry
-
NCT02254837
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT02254837. Allocation not applicable; no masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2018-06-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Zilver PTX Post-Market Study in Japan
- Condition
- Peripheral Arterial Disease (PAD)
- Intervention (Device)
- Zilver PTX Drug-Eluting Stent
- Lead sponsor
- Cook Group Incorporated
Record details
- Record id
cardio:ct-nct02254837- Content hash
4129ee86977d99e5d0e26f791c495cb3561b47ac4a44c7dbb32d43e13ef44a75